S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 (2014/12/16)|
|Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award (2014/12/5)|
|Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer (2015/1/5)|
|Webcast Alert: Isis Pharmaceuticals' 2014 Financial Results and Highlights Conference Call (2015/2/20)|
|Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics (2015/1/6)|
|Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery (2014/12/7)|
|Isis Pharmaceuticals Reports Data From Phase 2 Study of ISIS-PTP1B Rx in Patients With Type 2 Diabetes (2015/2/3)|
|Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract (2015/1/5)|
|Isis Reports Financial Results and Highlights for 2014 (2015/2/27)|
|Isis Pharmaceuticals Significantly Improves Upon 2014 Financial Guidance (2015/1/8)|
Click above to view more mutual fund data and stats for isis - Isis Pharmaceuticals.